# Methotrexate Monitoring Target Trial Emulation

> **NCT07512401** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 2414 (actual)

## Conditions studied

- Rheumatic Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Standard methotrexate lab monitoring
- **DIAGNOSTIC_TEST:** Reduced methotrexate lab monitoring

## Key facts

- **NCT ID:** NCT07512401
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 2414 (ACTUAL)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07512401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07512401, "Methotrexate Monitoring Target Trial Emulation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07512401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*